GlassScriptPhysician profile
George Stefanis
NPI 1578666780
$1,153.79
in general payments reported to CMS, 2019-2025
20 companies · $33.36 in 2025
The $33.36 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $14.71 · 2021: $22.20 · 2022: $132 · 2023: $150 · 2024: $386 · 2025: $33.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $209.47 | 2023-2025 | Evenity, Prolia |
| Boston Scientific Corporation | $164.78 | 2023-2024 | Superion Indirect Decompression System |
| Edwards Lifesciences Corporation | $117.46 | 2019 | |
| Ibsa Pharma INC. | $94.10 | 2022-2024 | Tirosint, Licart, Tirosint |
| Kyocera Medical Technologies, INC. | $93.74 | 2022-2024 | |
| Smith+Nephew, INC. | $87.81 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $67.38 | 2019-2020 | |
| Si-Bone, INC. | $61.31 | 2019-2024 | |
| Providence Medical Technology, INC. | $33.75 | 2019 | |
| Shionogi INC | $33.44 | 2019 | |
| Electronic Waveform Lab, INC. | $23.13 | 2019 | |
| Medtronic, INC. | $22.20 | 2021 | |
| Daiichi Sankyo INC. | $22.09 | 2019 | |
| Ethicon US, LLC | $21.72 | 2022 | |
| Averitas Pharma INC. | $21.50 | 2023 | Qutenza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $19.73 | 2025 | Angio-Seal |
| Zimvie INC. | $16.37 | 2023 | |
| Zimmer Biomet Holdings, INC. | $16.37 | 2023 | Ebi Osteogen Implantable Bone Growth Stimulator |
| Pfizer INC. | $13.89 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Stefanis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.